Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Cortes

Showing results (121-130 of 231) with videos related to

Pageof 24
Sort By:
ESMO Open|May 23, 2020
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast CancerEvandro de Azambuja, Dario Trapani, Sibylle Loibl, et al.
Future Oncology (London, England)|October 21, 2022
GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancerHope S Rugo, Javier Cortes, Carlos H Barrios, et al.
Breast Cancer Research and Treatment|May 5, 2026
Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?Lis Victória Ravani, Seth A Wander, Marleen Kok, et al.
Frontiers in Microbiology|March 15, 2021
Human Microbiota and Breast Cancer-Is There Any Relevant Link?-A Literature Review and New Horizons Toward Personalised MedicineDiogo Alpuim Costa, José Guilherme Nobre, Marta Vaz Batista, et al.
Journal of Medical Virology|April 14, 2012
Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE studyXavier Castellsagué, Thomas Iftner, Esther Roura, et al.
Cancer Medicine|March 14, 2023
Pembrolizumab plus chemotherapy in Japanese patients with triple-negative breast cancer: Results from KEYNOTE-355Masaya Hattori, Norikazu Masuda, Toshimi Takano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
HER2-Low Breast Cancer: Pathological and Clinical LandscapePaolo Tarantino, Erika Hamilton, Sara M Tolaney, et al.
Journal of the National Cancer Institute|January 27, 2021
The Global Landscape of Treatment Standards for Breast CancerDario Trapani, Jean Yves Douillard, Eric P Winer, et al.
Genome Medicine|January 6, 2019
Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNAMeiling Gao, Maurizio Callari, Emma Beddowes, et al.
Cancer Treatment Reviews|August 7, 2022
Rethinking breast cancer follow-up based on individual risk and recurrence managementFiorenza De Rose, Bruno Meduri, Maria Carmen De Santis, et al.
Pageof 24

Showing results (121-130 of 231) with videos related to

Sort By:
Pageof 24
ESMO Open|May 23, 2020
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast CancerEvandro de Azambuja, Dario Trapani, Sibylle Loibl, et al.
Future Oncology (London, England)|October 21, 2022
GLORIA: phase III, open-label study of adagloxad simolenin/OBI-821 in patients with high-risk triple-negative breast cancerHope S Rugo, Javier Cortes, Carlos H Barrios, et al.
Breast Cancer Research and Treatment|May 5, 2026
Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?Lis Victória Ravani, Seth A Wander, Marleen Kok, et al.
Frontiers in Microbiology|March 15, 2021
Human Microbiota and Breast Cancer-Is There Any Relevant Link?-A Literature Review and New Horizons Toward Personalised MedicineDiogo Alpuim Costa, José Guilherme Nobre, Marta Vaz Batista, et al.
Journal of Medical Virology|April 14, 2012
Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE studyXavier Castellsagué, Thomas Iftner, Esther Roura, et al.
Cancer Medicine|March 14, 2023
Pembrolizumab plus chemotherapy in Japanese patients with triple-negative breast cancer: Results from KEYNOTE-355Masaya Hattori, Norikazu Masuda, Toshimi Takano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
HER2-Low Breast Cancer: Pathological and Clinical LandscapePaolo Tarantino, Erika Hamilton, Sara M Tolaney, et al.
Journal of the National Cancer Institute|January 27, 2021
The Global Landscape of Treatment Standards for Breast CancerDario Trapani, Jean Yves Douillard, Eric P Winer, et al.
Genome Medicine|January 6, 2019
Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNAMeiling Gao, Maurizio Callari, Emma Beddowes, et al.
Cancer Treatment Reviews|August 7, 2022
Rethinking breast cancer follow-up based on individual risk and recurrence managementFiorenza De Rose, Bruno Meduri, Maria Carmen De Santis, et al.
Pageof 24